Brandywine Global Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-75,053
| Closed | -$3.7M | – | 562 |
|
|
2024
Q3 | $3.7M | Buy |
75,053
+938
| +1% | +$46.2K | 0.02% | 454 |
|
|
2024
Q2 | $2.96M | Buy |
+74,115
| New | +$2.96M | 0.02% | 501 |
|
|
2018
Q4 | – | Sell |
-12,800
| Closed | -$247K | – | 831 |
|
|
2018
Q3 | $247K | Hold |
12,800
| – | – | ﹤0.01% | 637 |
|
|
2018
Q2 | $196K | Hold |
12,800
| – | – | ﹤0.01% | 684 |
|
|
2018
Q1 | $240K | Buy |
+12,800
| New | +$240K | ﹤0.01% | 648 |
|
|
2016
Q3 | – | Sell |
-23,900
| Closed | -$386K | – | 935 |
|
|
2016
Q2 | $386K | Sell |
23,900
-325
| -1% | -$5.25K | ﹤0.01% | 632 |
|
|
2016
Q1 | $291K | Hold |
24,225
| – | – | ﹤0.01% | 645 |
|
|
2015
Q4 | $345K | Buy |
24,225
+16,345
| +207% | +$233K | ﹤0.01% | 638 |
|
|
2015
Q3 | $93K | Hold |
7,880
| – | – | ﹤0.01% | 799 |
|
|
2015
Q2 | $139K | Buy |
+7,880
| New | +$139K | ﹤0.01% | 768 |
|